DARPP-32 Antibodies

Santa Cruz Biotechnology delivers a wide array of DARPP-32 monoclonal antibodies for research focused on understanding neuronal signaling pathways. DARPP-32 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DARPP-32, or dopamine and cAMP-regulated phosphoprotein of 32 kDa, plays a significant role in the signaling pathways of neurons, particularly in the modulation of dopamine receptor activity. DARPP-32 is essential for the regulation of synaptic plasticity and has been implicated in various neurological disorders, making it a vital target for research in neurobiology and pharmacology. Understanding DARPP-32 function can provide insights into the mechanisms underlying addiction, schizophrenia, and other neuropsychiatric conditions. Researchers can explore DARPP-32's role in both normal physiological processes and disease states through specific detection methods. Advanced research techniques using DARPP-32 monoclonal antibodies enable detailed investigation of neural pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support neuroscience research advancement, contributing to a deeper understanding of neurological disorders and potential treatments.